A Health and Human Services (HHS) report released Monday reveals that despite a drop in brand prescriptions, shared costs saw a 40 percent increase from 2011-2015, according to a report on CBS.
The HHS inspector general’s office says the number of brand prescriptions under the Medicare Part D program fell 17 percent for the same time period.
“Increases in unit prices for brand-name drugs resulted in Medicare and its beneficiaries paying more for these drugs,” the report states.
The report says rising manufacturer prices are to blame.
To read more on CBS, click here.
The full HHS inspector general’s report can be found here.
